Format
Sort by

Send to

Choose Destination

Selected items

Items: 3

1.

Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.

Udeshi ND, Mani DR, Eisenhaure T, Mertins P, Jaffe JD, Clauser KR, Hacohen N, Carr SA.

Mol Cell Proteomics. 2012 May;11(5):148-59. doi: 10.1074/mcp.M111.016857. Epub 2012 Apr 14.

2.

Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.

Altun M, Kramer HB, Willems LI, McDermott JL, Leach CA, Goldenberg SJ, Kumar KG, Konietzny R, Fischer R, Kogan E, Mackeen MM, McGouran J, Khoronenkova SV, Parsons JL, Dianov GL, Nicholson B, Kessler BM.

Chem Biol. 2011 Nov 23;18(11):1401-12. doi: 10.1016/j.chembiol.2011.08.018.

3.

Large-scale analysis of the human ubiquitin-related proteome.

Matsumoto M, Hatakeyama S, Oyamada K, Oda Y, Nishimura T, Nakayama KI.

Proteomics. 2005 Nov;5(16):4145-51.

PMID:
16196087

Supplemental Content

Support Center